SEC Tracker
Get the app

Gossamer Bio GOSS

Gossamer Bio approves share issuance

Item 5.07 Shareholder vote results

Form
8-K
Filed
Importance
Routine
  1. 2,808,000 votes for, 37,814 against
  2. Approval of potential issuance of shares under Purchase Agreement
  3. Issuances could exceed 20% of outstanding shares

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Gossamer Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Tonix Pharmaceuticals Holding TNXP public float $271M, Jun 30, 2025
  2. Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025
  3. Abeona Therapeutics ABEO public float $273M, Jun 30, 2025
  4. Ocugen OCGN public float $279M, Jun 30, 2025
  5. Atea Pharmaceuticals AVIR public float $263M, Jun 30, 2025